Definium Therapeutics(DE:MMQ0)
€26.50+0.50 (+1.92%)
DE:MMQ0
Definium Therapeutics stock drug pipeline
€26.50
At close:+0.50 (+1.92%)
Definium Therapeutics (MMQ0) Drug Pipeline
14 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Definium Therapeutics, Inc. (DE:MMQ0) have in its pipeline
Definium Therapeutics DE:MMQ0 is currently developing the following drugs: Mm402 (R-Enantiomer Of 3,4-Methylenedioxymethamphetamine (Mdma)), Mm120 (Lsd D-Tartrate), Mm-120 (Lsd D-Tartrate), Mm-120. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

